191420 — Tego Science Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for Tego Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	8,300	7,678	7,772	6,759	5,941
Cost of Revenue
Gross Profit	6,403	5,615	5,304	4,776	4,036
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	8,398	7,469	10,102	8,989	10,365
Operating Profit	-98	210	-2,330	-2,230	-4,424
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	66.2	202	-2,563	2,839	-8,107
Provision for Income Taxes
Net Income After Taxes	47.5	256	-2,343	3,316	-7,021
Minority Interest
Net Income Before Extraordinary Items
Net Income	139	265	-2,323	3,350	-7,012
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	139	265	-2,323	3,350	-7,012
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	17.3	33	-197	418	-876
Dividends per Share